3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Wilms Tumor
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Filgrastim
10
Cyclophosphamide
8
X-Rays
6
Phantoms, Imaging
6
Granulocyte Colony-Stimulating Factor
6
Temozolomide
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ifosfamide
5
Carboplatin
5
Vincristine
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Etoposide
4
Busulfan
4
Topotecan
3
Thiotepa
3
Stem Cell Transplantation
3
Mesna
3
Cisplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
sargramostim
2
palbociclib
2
olaparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
pegylated granulocyte colony-stimulating factor
×
Sarcoma
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled